Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting

Annals of Internal Medicine

Volumn 140, Issue 10, 2004, Pages 795-801

  Nebeker, Jonathan R ^a   Barach, Paul ^b   Samore, Matthew H ^b  

^a GRECC (182)   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA ANALYSIS; DOCUMENTATION; DRUG SURVEILLANCE PROGRAM; INFORMATION PROCESSING; MEDICAL PRACTICE; NOMENCLATURE; PRIORITY JOURNAL; PUBLICATION;

EID: 2442433545     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-140-10-200405180-00009     Document Type: Article

References (37)

1. Ross SD. Drug-related adverse events: a readers' guide to assessing literature reviews and meta-analyses. Arch Intern Med. 2001;161:1041-6. [PMID: 11322836]
2. Shojania KG, Duncan BW, McDonald KM, Wachter RM. Safe but sound: patient safety meets evidence-based medicine [Editorial]. JAMA. 2002;288:508-13. [PMID: 12132985]
3. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Pr; 1999.
4. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29-34. [PMID: 7791255]
5. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-64. [PMID: 12700376]
6. Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol. 2000;49:158-67. [PMID: 10671911]
7. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847-51. [PMID: 1942452]
8. Tegeder I, Levy M, Muth-Selbach U, Oelkers R, Neumann F, Dormann H, et al. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol. 1999;47:557-64. [PMID: 10336581]
9. Nebeker JR, Hurdle JF, Hoffman JM, Roth B, Weir CR, Samore MH. Developing a taxonomy for research in adverse drug events: potholes and signposts. J Am Med Inform Assoc. 2002;9(6 Suppl):S80-5.
10. Schlienger RG, Luscher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21:110-5. [PMID: 10427579]
11. Johnstone DM, Kirking DM, Vinson BE. Comparison of adverse drug reactions detected by pharmacy and medical records departments. Am J Health Syst Pharm. 1995;52:297-301. [PMID: 7749958]
12. Sivaram CA, Johnson S, Tirmizi SN, Robertson V, Garcia D, Sorrells E. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv. 1996;22:259-63. [PMID: 8743062]
13. Thatcher C. ADR: reporting problems. Can Pharm J. 2002;134:11.
14. Hofer TP, Kerr EA, Hayward RA. What is an error? Eff Clin Pract. 2000;3:261-9. [PMID: 11151522]
15. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. London: European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit; 1995. Accessed at www.emea.eu.int/pdfs/human/ich/037795en.pdf on 16 December 2003.
16. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255-9. [PMID: 11072960]
17. Cobert BL, Biron P. Pharmacovigilance from A to Z. Malden, MA: Blackwell Science; 2002.
18. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109:87-94. [PMID: 10967148]
19. What Is a Medication Error? Rockville, MD: National Coordinating Council for Medication Error Reporting and Prevention; 1998. Accessed at www.nccmerp .org on 29 August 2003.
20. Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting E2D. Geneva, Switzerland: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2003. Accessed at www.ich.org/MediaServer.jser?@_ID=631& @_TYPE=MULTIMEDIA&@_TEMPLATE=616&@_MODE=GLB on 17 December 2003.
21. Venulet J, ten Ham M. Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther. 1996;34:112-29. [PMID: 8705089]
22. Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf. 1997;17:374-89. [PMID: 9429837]
23. Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm. 1986;43:1709-14. [PMID: 3752106]
24. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA. 1979;242:623-32. [PMID: 449002]
25. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45. [PMID: 7249508]
26. Bates DW. Medication errors. How common are they and what can be done to prevent them? Drug Saf. 1996;15:303-10. [PMID: 8941492]
27. Schaaf T, Van der Lucas DA, Hale AR, eds. Near Miss Reporting as a Safety Tool. Oxford: Butterworth-Heinemann; 1991.
28. Guideline for Postmarketing Reporting of Adverse Drug Experiences. Rockville, MD: U.S. Food and Drug Administration; 1992. Accessed at www.fda.gov/medwatch/safety/ade/t_cder.htm on 16 December 2003.
29. Andrews LB, Stocking C, Krizek T, Gottlieb L, Krizek C, Vargish T, et al. An alternative strategy for studying adverse events in medical care. Lancet. 1997;349:309-13. [PMID: 9024373]
30. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199-205. [PMID: 7790981]
31. Hurdle JF, Weir CR, Roth B, Hoffman J, Nebeker JR. Critical gaps in the world's largest electronic medical record: ad hoc nursing narratives and invisible adverse drug events. Proc AMIA Symp. 2003:309-12. [PMID: 14728184]
32. Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997;45:945-8. [PMID: 9256846]
33. Evans RS, Pestotnik SL, Classen DC, Bass SB, Burke JP. Prevention of adverse drug events through computerized surveillance. Proc Annu Symp Comput Appl Med Care. 1992:437-41. [PMID: 1482913]
34. Lucas LM, Colley CA. Recognizing and reporting adverse drug reactions. West J Med. 1992;156:172-5. [PMID: 1536067]
35. Wood AJ, Stein CM, Woosley R. Making medicines safer-the need for an independent drug safety board. N Engl J Med. 1998;339:1851-4. [PMID: 9854125]
36. Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, et al. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol. 2003;21:3859-66. [PMID: 14551305]
37. Ahmad SR. Adverse drug event monitoring at the Food and Drug Administration. J Gen Intern Med. 2003;18:57-60. [PMID: 12534765]